Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    20818855 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed HD10 for Early Stages
Condition: Hodgkin´s Lymphoma
Interventions: Drug: Adriamycin;   Drug: Bleomycin;   Drug: Vinblastine;   Drug: DTIC;   Radiation: 30 Gy IF-RT;   Radiation: 20 Gy IF-RT

Study has passed its completion date and status has not been verified in more than two years.